Press Releases Terumo Corporation

Equities

4543

JP3546800008

Market Closed - Japan Exchange Other stock markets 11:30:00 01/05/2024 am IST			5-day change	1st Jan Change
2,659 ^JPY	-1.28%		+1.49%	+15.06%

12/04	Penumbra, Inc. : The underdog in healthcare
18/03	Frontier Field Co., Ltd. announced that it has received funding from Terumo Corporation	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

IceCure Medical CEO Issues Letter to Shareholders and Reports Increase in Sales in Preliminary Unaudited 2023 Results	11/01	AQ
Terumo : Blood and Cell Technologies takes part in Connecting the DotsA new film series showcasing the pivotal role of medical technologies to improve healthcare	06/12	PU
Terumo : expands global presence with new subsidiary in South-Africa	30/11	PU
MicroVention Celebrates 10-Year Anniversary and Legacy of SOFIA™ Aspiration Catheters; More than 500,000 Procedures Performed Worldwide Across 170 Countries	16/11	BU
Terumo : India Introduces Insulin Syringe for Patients Requiring Daily Insulin Injections to Manage Diabetes	16/11	PU
Terumo : Olympus and Terumo Announce Change in Form of Contract	31/23/31	PU
Terumo : Blood and Cell Technologies launches study with BioCentriq® to generate public CAR-T cell data using Terumo BCT’s CGT manufacturing platformsData will detail how the Terumo BCT’s Quantum Flex® Cell Expansion System and Finia® Fill and Finish System with BioCentriq’s LEAP™ Advanced Therapy Platform can help accelerate delivery of CAR-T therapies to patients	06/23/06	PU
ANGIO-SEAL™ VIP & FEMOSEAL™ VASCULAR CLOSURE DEVICES SECURED CE CERTIFICATE UNDER THE NEW MEDICAL DEVICE REGULATIONTerumo (TSE: 4543) is proud to announce that both of our Vascular Closure Devices, Angio-Seal™ VIP & Femoseal™, received the EU MDR certifications.	06/23/06	PU
Terumo : to Cease Distributing Dexcom Continuous Glucose Monitoring Systems as Dexcom Moves to a Direct Distribution Model in Japan	02/23/02	PU
MicroVention Enters Transradial Access Therapy; Receives FDA Clearance of SOFIA™ EX 5F 115cm Intracranial Support Catheter	21/23/21	BU
Terumo : Financial Results for the First Quarter of Fiscal Year Ending March 31, 2024 (FY2023)(with note)	10/23/10	PU
Terumo : IFRS Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2024	09/23/09	PU
Terumo : Financial Results for the First Quarter of Fiscal Year Ending March 31, 2024 (FY2023)	09/23/09	PU
Terumo : Notice of Stock Change of Olympus Terumo Biomaterials	09/23/09	PU
Terumo : Blood and Cell Technologies’ Reveos® Automated Whole Blood Processing System Cleared by FDA for U.S. Commercial Use	02/23/02	PU
Terumo : Aortic Announces PMDA Approval for Thoraflex Hybrid in Japan	04/23/04	PU
Terumo : Announces Voting Results for the Election of Directors	27/23/27	PU
Terumo : Aortic Announces Launch of the Global Thoraflex Hybrid EXTEND Study	14/23/14	PU
Terumo : Blood and Cell Technologies Optimizing Cell Therapy Production Through Industry’s First Apheresis Training for Cell Therapy Manufacturers	25/23/25	PU
Terumo : Q&A Session at the Financial Results Briefing for the Fiscal Year Ended March 31, 2023 (FY2022)	17/23/17	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Terumo Corporation

Equities

4543

JP3546800008

Press Releases

Filters